AU1531901A - Human tnf receptor - Google Patents

Human tnf receptor

Info

Publication number
AU1531901A
AU1531901A AU15319/01A AU1531901A AU1531901A AU 1531901 A AU1531901 A AU 1531901A AU 15319/01 A AU15319/01 A AU 15319/01A AU 1531901 A AU1531901 A AU 1531901A AU 1531901 A AU1531901 A AU 1531901A
Authority
AU
Australia
Prior art keywords
tnf receptor
human tnf
human
receptor
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15319/01A
Inventor
Jeremy David Alistair Kitson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1531901A publication Critical patent/AU1531901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153 or CD154

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU15319/01A 1999-11-23 2000-11-21 Human tnf receptor Abandoned AU1531901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9927681 1999-11-23
GBGB9927681.8A GB9927681D0 (en) 1999-11-23 1999-11-23 Protein
PCT/GB2000/004438 WO2001038526A1 (en) 1999-11-23 2000-11-21 Human tnf receptor

Publications (1)

Publication Number Publication Date
AU1531901A true AU1531901A (en) 2001-06-04

Family

ID=10864996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15319/01A Abandoned AU1531901A (en) 1999-11-23 2000-11-21 Human tnf receptor

Country Status (3)

Country Link
AU (1) AU1531901A (en)
GB (1) GB9927681D0 (en)
WO (1) WO2001038526A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012963A2 (en) 1997-09-12 1999-03-18 Biogen, Inc. Cysteine rich receptors: trail
AU2002328173A1 (en) * 2001-08-07 2003-02-24 Genset S.A. Omoxin agonists and antagonists for use in the treatment of metabolic disorders
US7846438B2 (en) 2004-08-03 2010-12-07 Biogen Idec Ma Inc. Methods of promoting neurite outgrowth with soluble TAJ polypeptides
BR112012013330A2 (en) 2009-12-02 2017-03-28 Acceleron Pharma Inc compositions and methods for increasing fc fusion protein serum half life
EP2718328A4 (en) 2011-06-08 2014-12-24 Acceleron Pharma Inc Compositions and methods for increasing serum half-life

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620739A4 (en) * 1992-09-15 1997-01-15 Immunex Corp Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists.
AU9376498A (en) * 1997-09-05 1999-03-22 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
WO1999012963A2 (en) * 1997-09-12 1999-03-18 Biogen, Inc. Cysteine rich receptors: trail
AU2574200A (en) * 1999-02-19 2000-09-04 Toshio Kitamura Novel tnf receptor-like proteins

Also Published As

Publication number Publication date
WO2001038526A1 (en) 2001-05-31
GB9927681D0 (en) 2000-01-19

Similar Documents

Publication Publication Date Title
AU5274499A (en) Therapeutic chemokine receptor antagonists
AU4775900A (en) Muscle contraction assist device
AU5095000A (en) Receptor interacting protein rip3
AU6670700A (en) Sanitation unit
AU1229101A (en) Cervical immobilization
AU1557901A (en) Chair
HK1042099A1 (en) Human g-protein coupled receptor
IL148515A0 (en) Human g-protein coupled receptor
IL196053A0 (en) Novel human g-protein coupled receptor
AU2292301A (en) Human kinases
AU1073501A (en) Histamine receptor
EP1144628A3 (en) Human vanilloid receptor gene
AU1791501A (en) Imaging sexual response
AU2001277980A1 (en) Human cytokine receptor
AU3668499A (en) Human receptor molecules
AU8921198A (en) New human g-protein coupled receptor
AU6035398A (en) Human c5a-like receptor
AU1531901A (en) Human tnf receptor
AU4753496A (en) Human g-protein coupled receptor
AU4483500A (en) Human membrane-associated proteins
AU4849299A (en) Human emr1-like g protein coupled receptor
AU4416500A (en) Tomographic system
AU4456800A (en) Human hac3
AU4609101A (en) Cervical fitting
AU1210300A (en) Human retinoid-like orphan receptor gamma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase